Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Friend

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Cold Spring Harbor Symposia on Quantitative Biology|July 28, 2006
Emerging approaches in molecular profiling affecting oncology drug discoveryS H Friend
Science (New York, N.Y.)|February 5, 1993
Genetic models for studying cancer susceptibilityS H Friend
Clinical Pharmacology and Therapeutics|April 22, 2010
The need for precompetitive integrative bionetwork disease model buildingS H Friend
BMJ (Clinical Research Ed.)|November 24, 1999
How DNA microarrays and expression profiling will affect clinical practiceS H Friend
Nature Genetics|May 1, 1996
Breast cancer susceptibility testing: realities in the post-genomic eraS H Friend
Journal of the National Cancer Institute|October 6, 1993
The importance of p53 gene alterations in human cancer: is there more than circumstantial evidence?T Frebourg, S H Friend
Molecular and Cellular Biology|July 1, 1994
E2F and its developmental regulation in Xenopus laevisA Philpott, S H Friend
Science (New York, N.Y.)|February 12, 1993
Correction: a Li-Fraumeni syndrome p53 mutationD Malkin, S H Friend
Seminars in Cancer Biology|June 1, 1992
The role of tumour suppressor genes in familial cancerD Malkin, S H Friend
Current Opinion in Pediatrics|February 1, 1994
Screening for cancer susceptibility in childrenD Malkin, S H Friend
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Cold Spring Harbor Symposia on Quantitative Biology|July 28, 2006
Emerging approaches in molecular profiling affecting oncology drug discoveryS H Friend
Science (New York, N.Y.)|February 5, 1993
Genetic models for studying cancer susceptibilityS H Friend
Clinical Pharmacology and Therapeutics|April 22, 2010
The need for precompetitive integrative bionetwork disease model buildingS H Friend
BMJ (Clinical Research Ed.)|November 24, 1999
How DNA microarrays and expression profiling will affect clinical practiceS H Friend
Nature Genetics|May 1, 1996
Breast cancer susceptibility testing: realities in the post-genomic eraS H Friend
Journal of the National Cancer Institute|October 6, 1993
The importance of p53 gene alterations in human cancer: is there more than circumstantial evidence?T Frebourg, S H Friend
Molecular and Cellular Biology|July 1, 1994
E2F and its developmental regulation in Xenopus laevisA Philpott, S H Friend
Science (New York, N.Y.)|February 12, 1993
Correction: a Li-Fraumeni syndrome p53 mutationD Malkin, S H Friend
Seminars in Cancer Biology|June 1, 1992
The role of tumour suppressor genes in familial cancerD Malkin, S H Friend
Current Opinion in Pediatrics|February 1, 1994
Screening for cancer susceptibility in childrenD Malkin, S H Friend
Pageof 8